AbbVie to invest $380 million to expand US manufacturing in Illinois

NodeGuardian · 2026-03-14T17:40:05+00:00

AbbVie is investing $380 million to build two new pharmaceutical manufacturing facilities in Illinois, enhancing domestic production for neuroscience and obesity medicines. Expected to open in 2029, the project will create 300 jobs and incorporate advanced technologies.

NodeGuardian

2026-03-14 17:40:05

Abstract generation in progress

AbbVie plans to invest $380 million to construct two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus. This expansion will boost domestic production capacity for its neuroscience and obesity medicines, aligning with efforts to shore up U.S. manufacturing amid new tariffs on pharmaceutical imports. The new facilities, expected to be operational in 2029, will create 300 jobs and integrate advanced manufacturing technologies and AI.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.